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ABSTRACT 
Congenital abdominal wall defects are a group of malformations among which 
gastroschisis and omphalocele are the most common. In omphalocele, abdominal 
organs are herniated through an open umbilical ring and the defect is covered by 
membranes. Omphalocele is often associated with other severe anomalies and 
reasonably high mortality. Gastroschisis, on the other hand, is an open abdominal 
wall defect lateral to the umbilical cord. Contrary to omphalocele, it carries a far 
better prognosis. For unknown reasons, the prevalence of gastroschisis has increased 
dramatically worldwide over the last decades. 
The first aim of this study was to assess the national prevalence, mortality, and 
pregnancy termination rates of both gastroschisis and omphalocele, and to identify 
associated anomalies. In the second phase, the aim was to identify potential maternal 
risk factors for both abovementioned anomalies. The analysis is based on several 
national registries, the majority of which are upheld by the Finnish Institute for 
Health and Welfare. 
The prevalence and mortality rates of both gastroschisis and omphalocele in 
Finland were comparable with previous worldwide reports. However, the pregnancy 
termination rate for gastroschisis was significantly higher than previously reported 
and it was speculated to be due to insufficient antenatal counselling. Young maternal 
age was a risk factor for gastroschisis. Obesity and diabetes increased the risk of 
omphalocele, while maternal obesity was protective for gastroschisis. In general, 
maternal prescription drug exposures during early pregnancy appeared safe, and 
extended spectrum penicillins significantly reduced the risk of omphalocele. 
In conclusion, survival for congenital abdominal wall defects in Finland is high 
and comparable with other high-income countries. Novel association between 
extended spectrum penicillins and the risk of omphalocele warrants further studies. 
KEYWORDS: abortion, congenital abdominal wall defect, exomphalos, 
gastroschisis, infant mortality, omphalocele, prevalence, risk factor   
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TIIVISTELMÄ 
Synnynnäiset vatsanpeitepuutokset ovat ryhmä malformaatioita, joista gastroskiisi 
ja omfaloseele ovat yleisimpiä. Omfaloseelessä vatsaontelon elimet hernioituvat 
avoimen naparenkaan läpi ja defekti on napanuoran kalvojen peittämä. 
Omfaloseeleen liittyy usein muita vakavia anomalioita ja myös suhteellisen suuri 
kuolleisuus. Gastroskiisi puolestaan on avoin vatsanpeitepuutos napanuoran oikealla 
puolen, jossa ennuste, toisin kuin omfaloseelessa, on useimmin erittäin hyvä. 
Gastroskiisi on useimmiten isoloitu anomalia. Tuntemattomista syistä gastroskiisin 
prevalenssi on ollut maailmanlaajuisesti kasvussa viimeisten vuosikymmenten ajan. 
Tutkimuksen ensimmäinen tavoite oli selvittää sekä omfaloseelen että 
gastroskiisin kansallinen prevalenssi, mortaliteetti, raskaudenkeskeytyksen yleisyys 
ja näihin liittyvät liittännäisanomaliat. Toisessa vaiheessa tavoitteena oli etsiä 
yllämainittujen anomalioiden mahdollisia äitiin liittyviä riskitekijöitä. Tutkimus 
perustuu useiden kansallisten rekisterien aineistoon, jotka suurelta osin ovat 
Terveyden ja Hyvinvoinnin laitoksen ylläpitämiä. 
Sekä gastroskiisin että omfaloseelen prevalenssi ja kuolleisuus Suomessa olivat 
yhteneviä aiempien julkaistujen tulosten kanssa. Gastroskiisin abortointi sen sijaan 
oli merkittävästi yleisempää kuin aiemmissa julkaisuissa, ja tämä saattaa johtua 
perheiden riittämättömästä informoinnista/ohjauksesta. Äidin nuori ikä oli riskitekijä 
gastroskiisille. Ylipaino ja diabetes sen sijaan altistivat omfaloseelelle, mutta 
toisaalta äidin ylipaino suojeli gastroskiisilta. Raskauden alkuvaiheessa käytetty 
lääkitys ei lisännyt vatsanpeitepuutosten riskiä. Tupakointi lisäsi gastroskiisin riskiä, 
mutta ei tilastollisesti merkittävästi. Laajakirjoisilla penisilliineillä alkuraskauden 
aikana todettiin omfaloseelen suhteen suojaavia vaikutuksia. 
Vatsanpeitepuutosten osalta kuolleisuus Suomessa on samaa tasoa kuin muissa 
korkean tuloluokan maissa. Penisilliinien vaikutus omfaloseelen riskiin on uusi 
löydös ja vaatii lisätutkimuksia tulosten varmistamiseksi. 
AVAINSANAT: abortti, gastroskiisi, imeväiskuolleisuus, napanuoratyrä, 
omfaloseele, prevalenssi, raskaudenkeskeytys, riskitekijä, synnynnäinen vatsan-
peitepuutos, vatsahalkio 
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1 Introduction 
Abdominal wall defects are a group of severe congenital anomalies. Even though 
this group includes several different diagnoses, all these malformations can be 
characterized by defective abdominal wall structures causing herniation of 
abdominal contents. This study concentrates on the two most common abdominal 
wall defects – namely gastroschisis and omphalocele. 
Gastroschisis is an open defect lateral to the umbilical cord. Known risk factors 
for gastroschisis include young maternal age, maternal smoking, recreational drugs, 
poor socioeconomic status, and malnutrition (Loane et al. 2007, Draper et al. 2008, 
Hackshaw et al. 2011, Friedman et al. 2016). However, there are only a few studies 
on the association of maternal prescription drugs in early pregnancy and the risk of 
gastroschisis (Werler et al. 2002, Ahrens et al. 2013, Given et al. 2017, Anderson, 
K. N. et al. 2020). In most cases, gastroschisis is an isolated anomaly and survival in 
high income countries exceed 90% (Lao et al. 2010, Owen et al. 2010, Cowan et al. 
2012, Bhatt et al. 2018, Anderson, J. E. et al. 2018). For unclear reasons, the 
worldwide prevalence has been increasing (Bhatt et al. 2018, Anderson, J. E. et al. 
2018). However, most of these studies have lacked total prevalence. 
Omphalocele, or exomphalos, is also an abdominal wall defect involving 
herniation of bowel and occasionally other abdominal organs. Contrary to 
gastroschisis, the defect in omphalocele is covered with membranes of the abdominal 
wall and the umbilical cord (Khan et al. 2019). Omphalocele is often associated with 
other congenital anomalies, including cardiac defects and chromosomal 
abnormalities, and hence associated with high morbidity and even mortality 
(Yazbeck et al. 1986, Byron-Scott et al. 1998, Stoll et al. 2001, Deng et al. 2014). 
There are a number of recognized risk factors for omphalocele, including advanced 
or very young maternal age (Salihu et al. 2003, Frolov et al. 2010), alcohol 
consumption during pregnancy (Bird et al. 2009), smoking (Bird et al. 2009, 
Feldkamp et al. 2014), maternal obesity (Waller et al. 2007), inflammatory bowel 
disease (Auger et al. 2020), disorders of glycaemic control (Waller et al. 2001), and 
male gender (Goldkrand et al. 2004). Regardless, the possible association of 
maternal use of prescription medicine during early pregnancy has only been 
Arimatias Raitio 
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addressed in a handful of studies (Stoll et al. 2001, Alwan et al. 2007, Lin et al. 2012, 
Kapapa et al. 2019). 
The national register data in Finland is upheld by the Finnish Institute of National 
Health and Welfare. The quality and coverage of the registers has been validated in 
multiple national and international investigations (Gissler et al. 1995, Pakkasjärvi et 
al. 2006, Leoncini et al. 2010, Artama et al. 2011). The aforementioned data was 
combined with the data on maternal prescription medicine use from the Register on 
Reimbursed Drug Purchases by the Finnish Social Insurance Institution (Kela). As 
foetal structures and organs are most susceptible to teratogenic effects at 3–8 weeks 
after conception (Moore & Persaud 2003), we limited this data to a time window of 
one month prior conception and the first trimester of pregnancy. 
The first aim of this thesis was to assess the prevalence, mortality, and the rates 
of termination of pregnancy of gastroschisis and omphalocele in the Finnish 
population between 1993 and 2014, and to identify possible long-term changes in 
trends and the most commonly associated malformations. As very little is known 
about the associations of maternal prescription drugs and the risk of abdominal wall 
defects, we sought to address this question in the second part of this study. 
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2 Review of the Literature 
Gastroschisis and omphalocele were first described as early as the 16th century 
(Mayer et al. 1980). First survivors were described as early as 1802 for omphalocele 
(Hey 1802) and 1878 for gastroschisis (Fear 1878). Skin flap coverage for congenital 
abdominal wall defects was first introduced in 1887 (Olshausen 1887). Staged 
reduction and repair was introduced in 1967 as an alternative treatment modality for 
large congenital abdominal wall defects (Schuster 1967). For a long time 
gastroschisis was thought to be a ‘ruptured omphalocele’. Until 1953, they were 
described as separate entities (Moore, T. C. & Stokes 1953), and in 1963, Duhamel 
emphasized their distinct pathogenesis and clinical presentation (Duhamel 1963). 
For this thesis, a PubMed search with relevant keywords for epidemiology and risk 
factors of omphalocele and gastroschisis was performed concentrating on most 
recent publications. A summary of these studies published in the last 20 years is 
presented in Tables 2 & 4. 
2.1 Embryology 
The development of both defects is essentially related to the embryology of the 
abdominal wall, and therefore it is helpful to understand the normal development of 
the ventral body wall. During the second week of gestation, the embryo is a 2 layered 
flat disk, which is then converted into three layers (ectoderm, mesoderm and 
endoderm) during the third week of foetal development in a process called 
gastrulation (Sadler 2010). The dorsally located ectoderm will later form the central 
nervous system, skin, and sensory organs. Mesoderm in the middle will make 
skeletal and connective tissues, the cardiovascular system, and the urogenital system. 
The ventral layer is endoderm and gives rise to the gut, liver, pancreas, and gall 
bladder.  At this stage, the circumference of the flat embryo represents the eventual 
umbilical ring (Khan et al. 2019). A combination of parietal mesoderm and ectoderm 
comprises the body wall and forms lateral body folds, which eventually fuse in the 
midline to close the ventral body wall (Sadler 2010). Leaving only umbilical vessels 
in the region of the umbilical ring, this process is finalized by the tenth week of 
Arimatias Raitio 
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gestation (Moore, K. L. et al. 2011). Coordinated cell death and deposition is 
responsible for the decrease in the size of the umbilical ring (Khan et al. 2019). 
2.2 Gastroschisis 
Gastroschisis is an open abdominal wall defect, almost always on the right to the 
umbilical cord (Figure 1). Gastroschisis derives from two Greek words: gastro 
(stomach or belly) and schisis (cleft or to split). Herniated bowel loops are in direct 
contact with amniotic fluid, causing a chemical peritonitis. In high-income countries, 
over 90% of the cases are detected in antenatal ultrasound screening (Rossi & 
Prefumo 2013, Fleurke-Rozema et al. 2017). These infants tend to be born slightly 
prematurely, on 36 weeks of gestation on average (Brindle et al. 2012, Overcash et 
al. 2014). Caesarean section is often the choice of delivery method, even though 
evidence does not associate mode of delivery with mortality (Brebner et al. 2018, 
Lopez et al. 2019). Usually only bowel loops are herniated through the defect but 
sometimes also stomach, urinary bladder, or liver. Herniated bowels can appear 
relatively normal (Figure 1) but may also show evidence of matting and bowel 
damage in some cases (Christison-Lagay et al. 2011). Both males and females are 
affected equally (Anderson, J. E. et al. 2018, Bhatt et al. 2018). 
2.2.1 Embryology 
The pathogenesis of gastroschisis is largely unknown. The closure of body walls 
occurs in early weeks of pregnancy and failure in this process leads to a defect 
(Sadler, T. W. & Feldkamp 2008). Neural tube defects occur with dorsal wall failure 
and ventral wall failures cause various defects, including gastroschisis, ectopia 
cordis and bladder and cloacal exstrophy. However, it has also been hypothesised 
that gastroschisis might be a result of disruption or thrombosis of umbilical 
vasculature in early pregnancy (Raveenthiran 2012). The most recent evidence 
suggests, however, that gastroschisis is a primary midline malformation of the 
umbilical ring (Rittler, Monica et al. 2013, Bargy & Beaudoin 2014, Opitz et al. 
2019), possibly resulting from the rupture of the physiological hernia (Beaudoin 
2018). Regardless, it seems clear that the clinical window of susceptibility for 
teratogenic exposures occurs early, in the first trimester of pregnancy (Feldkamp & 
Botto 2008). 
Review of the Literature 
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Figure 1.  A newborn with a typical case of gastroschisis. Stomach and most of the small bowel 
herniated through the defect lateral to the umbilical cord. 
2.2.2 Prevalence 
Gastroschisis occurs in western countries in 2.1 to 5.3 per 10,000 live births (Bhatt 
et al. 2018, Fleurke-Rozema et al. 2017, Anderson, J. E. et al. 2018, Castilla et al. 
2008). Latest reported prevalence in Finland was 2.7 per 10,000 births by the Finnish 
Institute of Health and Welfare (Kiuru-Kuhlefelt & Lahesmaa-Korpinen 2017). 
However, much lower prevalence rates have been reported in Asian countries: 
Taiwan, Japan, and Singapore all reported prevalence rates around 0.5 per 10,000 
live births (Suita et al. 2000, Tan et al. 2008, Chen, M. et al. 2019). On the other 
hand, Greenland reported very high prevalence (10.7 per 10,000 births) in their 
population-based study (Bugge, Merete et al. 2017). The rate for termination of 
pregnancy among antenatally detected cases varies from 0 to 14% (Fleurke-Rozema 
et al. 2017, Nicholas et al. 2009, Ekin et al. 2015). For unknown reasons, the 
worldwide prevalence has been steadily rising over the last decades, and a similar 
trend was observed in Finland as early as the 1970s (Hemminki et al. 1982). This 
has been reported in the majority of the published and reviewed articles as seen in 
Table 2. China (Xu et al. 2011), Taiwan (Chen, M. et al. 2019) and the US (Clark et 
al. 2020) appear to be the only exceptions regarding the worldwide increasing trend 
Arimatias Raitio 
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in the prevalence of gastroschisis. However, many of these studies have lacked total 
prevalence (Castilla et al. 2008, Bhatt et al. 2018, Anderson, J. E. et al. 2018). No 
explanation for this increasing trend has been found, but theories have suggested that 
this might be due to increased teen pregnancies, increased illicit substance abuse 
during pregnancy, and more frequent chemical exposures (Winchester et al. 2009, 
Souther et al. 2017, Short et al. 2019). Interestingly, the prevalence has not only been 
increasing among young mothers but rather in all age groups (Loane et al. 2007, Vu 
et al. 2008, Chabra et al. 2011, Robledo-Aceves et al. 2015). 
2.2.3 Risk Factors 
Even though the pathophysiology behind gastroschisis is not completely clear, there 
are several well-recognized risk factors for gastroschisis, among which young 
maternal age is the most consistent (Table 1) (Anderson, J. E. et al. 2018, Vu et al. 
2008, Chabra et al. 2011, Robledo-Aceves et al. 2015, Kapapa et al. 2019, Stallings 
et al. 2019, Dewberry et al. 2020). Similarly, smoking, alcohol consumption, and the 
use of recreational drugs during pregnancy increase the risk of gastroschisis (Bird et 
al. 2009, Hackshaw et al. 2011, Perry et al. 2019, Hawkins & Baum 2019, Freitas et 
al. 2020, Baldacci et al. 2020, Draper et al. 2008, Richardson et al. 2011, Dewberry 
et al. 2020). These exposures are often associated with low socioeconomic status, 
which is also a known risk factor of gastroschisis (Bronberg et al. 2020). Regional 
opioid prescription rates in the US appear to have a correlation with the prevalence 
of gastroschisis (Short et al. 2019). Some environmental factors, especially 
pesticides, have been associated with the higher risk of gastroschisis (Mattix et al. 
2007, Waller, Sarah A. et al. 2010, Souther et al. 2017). As nulliparity and short 
cohabitation are also significant risk factors, it has been hypothesised that antigenic 
or immunological factors might be involved in the origin of gastroschisis (Rittler, M. 
et al. 2007, Duong et al. 2012). An increased risk of gastroschisis has been found 
with herpes infection and/or antiherpetic medication (Ahrens et al. 2013). Chlamydia 
and urinary tract infections are also associated with an increased risk of gastroschisis 
(Dewberry et al. 2020, Freitas et al. 2020). Similarly, limited, and yet consistent, 
evidence suggest that pseudoephedrine in early pregnancy is associated with an 
increased risk of gastroschisis (Werler, M. M. et al. 1992, Werler et al. 2002, Torfs 
et al. 1996). Maternal use of SSRI medication in early pregnancy is also associated 
with an increased risk of gastroschisis (Anthony Wemakor et al. 2015). Contrary to 
all these abovementioned factors, maternal obesity has been consistently associated 
with a significantly decreased risk of gastroschisis even though no explanation for 
this association has been found (Stothard et al. 2009, Khodr et al. 2013, Jenkins et 
al. 2014, Baer et al. 2015). Reports on the association of pregestational and 
gestational diabetes and the risk of gastroschisis remain controversial. A Canadian 
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study (Skarsgard et al. 2015) found history of gestational or pregestational diabetes 
to be associated with an increased risk of gastroschisis, while protective influence of 
diabetes was reported by US (Baer et al. 2015) and European (Given et al. 2017) 
groups. 
Table 1.  Influence of different exposures and factors on the risk of gastroschisis. 
Increased Risk Reduced Risk Controversial 
Young maternal age 
Alcohol 
Smoking 
Substance abuse 
Nulliparity 
Short cohabitation 
Pseudoephedrine 
SSRI 
Maternal obesity Maternal diabetes 
2.2.4 Treatment 
Most often (>90%) these infants have an antenatal diagnosis before delivery, 
allowing obstetrical, neonatal, surgical, and anaesthetic teams to prepare for initial 
care (Rossi & Prefumo 2013, Fleurke-Rozema et al. 2017). When the infant is born, 
vitality of the herniated bowel is confirmed, and the defect is most often covered 
with cling film to reduce heat and fluid loss. A nasogastric (NG) tube on free 
drainage and a rectal examination to evacuate meconium aids to decompress the 
intestines. Also, a minimum of one intravenous cannula is inserted. If the infant is 
not born in a paediatric surgical centre, transport is organised urgently after initial 
resuscitation. Subsequently, the infant is taken to operating theatre aiming for 
reduction of the bowel and primary closure of the defect with or without sutures 
(Figure 2). If primary closure is deemed impossible or too risky due to increased 
intra-abdominal pressure, a silo is placed or formed. The surgeon can choose 
between a preformed silastic silo or a custom-made, sutured silo. If a silo is placed, 
the bowel contents are then gradually reduced within the silo during the following 
days, and later closed when closure of the defect is deemed possible (Klein, Michael 
D. 2012). As all these infants will require parenteral nutrition (PN) for days or even 
weeks, placement of a central venous access should be considered at the time of 
primary operation, especially in cases with intestinal atresia. (Klein, Michael D. 
2012) Enteral feeds can be started as soon as bilious NG tube aspirates cease. 
Arimatias Raitio 
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The optimal method of closure is currently under debate, and several recent 
studies have addressed the advantages and disadvantages between sutureless and 
sutured abdominal wall closure. Prospective studies on this have not been published 
to date, but currently a US group is planning to conduct one. (Fraser et al. 2020) In 
retrospective cohorts and meta-analyses, sutureless closure appears to be associated 
with less general anaesthetics, antibiotic use, surgical site and deep infections, and 
decreased ventilator time and requirement for pain medication. (Youssef et al. 2016, 
Miyake et al. 2019, Grabski et al. 2019, Witt et al. 2019, Fraser et al. 2020) 
According to Miyake et al., sutureless closure can be considered and may be 
beneficial even after silo formation. (Miyake et al. 2019) The data on umbilical 
hernias requiring surgical repair is controversial. Sutureless closure had equivalent 
or superior outcomes regarding fascial closure according to systematic review and 
meta-analysis by Youssef et al. (Youssef et al. 2016) A retrospective single-centre 
cohort, however, had considerably more umbilical hernias requiring surgery with 
sutureless flap repair. (Witt et al. 2019) Given the concerns of the effects of general 
anaesthesia on the developing brain, sutureless closure should be considered 
especially in those cases where general anaesthesia can be avoided. (Grabski et al. 
2019) 
Gastroschisis is associated with abnormal intestinal motility, and introduction of 
enteral feeds may often take several weeks. During this period of dysmotility, 
nasogastric decompression and parenteral nutrition are required. To minimize the 
risk of oral aversion, it is important to introduce early oral stimulation. Necrotizing 
enterocolitis (NEC) is a risk even for full-term infants with gastroschisis. 
(Christison-Lagay et al. 2011) Long-term outcomes are generally excellent, and the 
majority will achieve normal growth and development after an initial catch-up period 
in early childhood. (Henrich et al. 2008) 
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Figure 2.  Post-operative situation in operating theatre after bowel reduction and sutureless 
closure of gastroschisis. Note the central venous line in the right internal jugular vein 
inserted by the anaesthetist with ultrasound guidance. 
2.2.5 Associated Anomalies 
In most cases gastroschisis is an isolated anomaly. However, so called complex 
gastroschisis with bowel atresia, damage, or obstruction occurs in 13 to 21% of the 
cases. (Bergholz et al. 2014, Mutanen et al. 2018, Bhatt et al. 2018) Up to one third 
of gastroschisis patients have associated anomalies including cardiac defects in 2 to 
15%, among which ventricular septal defect (VSD), atrial septal defect (ASD), and 
patent ductus arteriosus (PDA) are the most common. (Garne et al. 2005, Akhtar et 
al. 2012, Benjamin, B. & Wilson 2015, Benjamin, Bonna & Wilson 2014) Other 
associated anomalies in previous reports include central nervous system (2–10%, 
hydrocephaly, anencephaly, and spina bifida being the most common), 
musculoskeletal structures (<1–20%, limb reduction defects and arthrogryposis 
being the most common), genitourinary system (3–24%, hypospadias and renal 
agenesis being the most common), facial anomalies (1–3%, cleft lip ± palate), and 
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chromosomal abnormalities (<1–3%, trisomies and other syndromes) (Snyder et al. 
2001, Klein, Michael D. 2012, Benjamin, Bonna & Wilson 2014). Due to the 
possibility of associated malformations, appropriate investigations, i.e. ultrasound of 
abdomen and spine, are performed during the stay at the neonatal unit, and cardiac 
echo usually prior to surgery. 
2.2.6 Outcome 
Pregnancies with gastroschisis are often complicated and at risk for miscarriage or 
stillbirth. It is estimated that foetal demise occurs in 2.5 to 15% of the pregnancies 
affected by gastroschisis (Brantberg et al. 2004, Nicholas et al. 2009, Fleurke-
Rozema et al. 2017). Once born, however, the overall survival rates exceed 90% 
given that appropriate obstetric and neonatal care are provided (Lao et al. 2010, 
Owen et al. 2010, Cowan et al. 2012, Bhatt et al. 2018, Anderson, J. E. et al. 2018). 
Even mortality rates <5% have been reported with no statistical significance between 
simple and complex cases of gastroschisis (Bhatt et al. 2018, Anderson, J. E. et al. 
2018). The condition of the bowel at the time of surgery is a predictor of a more 
prolonged hospital stay, morbidity, and mortality (Abdullah et al. 2007). 
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Table 2.  Summary of prevalence rates and risk factors of gastroschisis reported in literature.  
Author  
(data collection years) 
Country 
Type of study 
(n=number of cases) 
Prevalence 
(per 10,000) 
Main findings 
Dewberry et al. 2020 
(2007 – 2016) 
USA 
Retrospective case-
control study (n=236) 
- Risk factors: Young maternal 
age, cigarette exposure, 
alcohol, and chlamydia 
infection 
Freitas et al. 2020 
(2013 – 2015) 
Brazil 
Retrospective case-
control study (n=57) 
- Risk factors: Alcohol, 
tobacco, and urinary tract 
infection 
Stallings et al. 2019 
(2012 – 2016) 
USA 
Retrospective study 
(n=5,349) 
4.3 Young maternal age (<25) 
underweight/normal weight 
Kapapa et al. 2019 
(2000 – 2011) 
Germany 
Retrospective case-
control study (n=36) 
13.1 (in hospital) Risk factors: young maternal 
age, short cohabitation time, 
antibiotics, alcohol 
consumption, and immune 
diseases 
Chen et al. 2019 
(1998 – 2013) 
Taiwan 
Retrospective study 
(n=179) 
0.50 Low prevalence 
Short et al. 2019 
(2006 – 2015) 
USA 
Retrospective study 
(n=2,249) 
4.2 Higher prevalence in 
counties with high opioid 
prescription rates 
Wittekindt et al. 2019 
(2010 – 2015) 
Germany 
Retrospective study 
(n=55) 
1.79 Comparable with previous 
data 
Anderson et al. 2018 
(1998 – 2011) 
USA 
Retrospective case-
control study (n=1,381) 
 
2.7 Risk factors: Young maternal 
age and unspecified 
substance exposure 
Bhatt et al. 2018 
(2010 – 2014) 
USA 
Retrospective study 
(n=8,700) 
4.9 Increasing prevalence 
Salinas-Torres et al. 
2018 (2000 – 2014) 
 
 
 
Mexico 
Retrospective study 
(n=10,287) 
4.01 Increasing prevalence 
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Singh & Kumar 2017 
(1992 – 2012) 
Barbados 
Retrospective study 
(n=14) 
2.22 High mortality (28.5%) 
Bugge et al. 2017 
(1989 – 2015) 
Greenland 
Retrospective study 
(n=28) 
10.7 (birth 
prevalence) 
Increasing and highest 
reported prevalence of 
gastroschisis 
Souther et al. 2017 
(2008 – 2015) 
USA (Hawaii) 
Retrospective study 
(n=71) 
- Pesticides may contribute to 
the development of 
gastroschisis 
Given et al. 2017 
(1995 – 2012) 
Europe 
Retrospective case-
control study (n=1,577) 
- Risk factors: antidepressant 
use, sexually transmitted 
infections, topical antivirals 
Campaña et al. 2017 
(1967 – 2013) 
Argentina 
Retrospective case-
control study (n=864) 
- High risk of gastroschisis 
related to repeated 
miscarriages  
Kong et al. 2016 
(1992 – 2009) 
Australia 
Retrospective study 
(n=336) 
3.3 Increasing prevalence 
Wemakor et al. 2015 
(1995 – 2009) 
Europe 
Retrospective case-
control study (n=413) 
- SSRI use increased risk 
Benjamin & Wilson 
2014 (1999 – 2008) 
USA 
Retrospective study 
(n=1,831) 
4.8 Large number with 
associated anomalies (32%) 
Ahrens et al. 2013 
(1997 – 2007) 
USA 
Retrospective case-
control study (n=941) 
- Risk factors: antiherpetic 
medication and/or herpes 
infection 
Richardson et al. 2011 
(1997 – 2005) 
USA 
Retrospective case-
control study (n=720) 
- Periconceptual alcohol 
consumption increased risk 
Xu et al. 2011 
(1996 – 2007) 
China 
Retrospective study 
(n=1,601) 
2.54 No change in prevalence 
Whitehall et al. 2010 
(1988 – 2007) 
Australia 
Retrospective study 
(n=59) 
3.2 Increasing prevalence 
Mac Bird et al. 2009 
(1997 – 2003) 
 
 
 
USA 
Retrospective case-
control study (n=485) 
- Moderate risk factors: 
tobacco, alcohol, and 
ibuprofen 
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Fillingham et al. 2008 
(1997 – 2006) 
UK 
Retrospective study 
(n=143) 
4.28 (birth) Increasing prevalence 
Stoll et al. 2008 
(1979 – 2003) 
France 
Retrospective study 
(n=60) 
1.79 Often isolated anomaly 
Draper et al. 2008 
(2001 – 2003) 
UK 
Retrospective case-
control study (n=165) 
- Risk factors: Tobacco, 
aspirin, and recreational 
drugs 
Tan et al. 2008 
(1993 – 2002) 
Singapore 
Retrospective study 
(n=21) 
0.46 Increasing prevalence 
Loane et al. 2007 
(1980 – 2002) 
Europe 
Retrospective study 
(n=936) 
0.54  2.12 Increasing prevalence 
Laughon et al. 2003 
(1997 – 2000) 
USA 
Retrospective study 
(n=149) 
1.96  4.49 Increasing prevalence 
Salihu et al. 2003 
(1992 – 1999) 
USA 
Retrospective study 
(n=308) 
1.43 Increasing prevalence 
Bugge et al. 2002 
(1970 – 1989) 
Denmark 
Retrospective study 
(n=166) 
1.33 (births) Increasing prevalence 
Stoll et al. 2001 
(1979 – 1998) 
France 
Retrospective case-
control study (n=47) 
1.76 Risk factor: medication 
during pregnancy 
Suita et al. 2000 
(1975 – 1997) 
Japan 
Retrospective study 
(n=970) 
0.13 – 0.47 Increasing prevalence 
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2.3 Omphalocele 
Omphalocele or exomphalos is a congenital abdominal wall defect where the 
herniated bowels, and sometimes liver, are covered by a membranous sac consisting 
of three layers: inner and outer layers being continuation of peritoneum and amnion, 
respectively, and the middle layer which is called Wharton’s jelly (Khan et al. 2019) 
(Figure 3). Both terms derive from Greek: omphalos (navel) and cele (hernia). 
Hence, the literal meaning of exomphalos is “outside the navel” and omphalocele is 
“hernia of the navel”. The vast majority of the cases are picked up in antenatal 
ultrasound screening and as high as 96% detection rates have been reported (Fleurke-
Rozema et al. 2017). In general, infants with omphalocele tend to be born 
prematurely (Gong et al. 2016), especially those with chromosomal defects 
(Marshall et al. 2015). The size of the defect and herniation varies markedly, ranging 
from minor bowel herniation (Figure 3) to giant omphaloceles, where the majority 
of abdominal contents are herniated (Figure 4). Males are affected more often by 
omphalocele than females (Marshall et al. 2015). 
 
Figure 3.  A small omphalocele with minimal herniation of abdominal contents. 
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2.3.1 Embryology 
There are several theories on the embryologic basis of the development of 
omphalocele. The pathogenesis is thought to be related to the development of ventral 
body wall, the amnion, and the umbilical ring occurring in early weeks of pregnancy 
(Khan et al. 2019). Suggested theories include failure of union of the mesodermal 
septum (Margulies 1945), germinal disc defects (Herva & Karkinen-Jääskeläinen 
1984), embryonic dysgenesis due to malformation of ectodermal placodes (Hartwig 
et al. 1989, Russo et al. 1993), and defective cell-signalling between the lateral and 
ventral body walls (Brewer & Williams 2004). The most widely accepted theory 
explaining the development of exomphalos is a malfunction of the ectodermal 
placodes combined with embryonic dysplasia (Khan et al. 2019). 
 
Figure 4. A giant omphalocele with herniated bowels covered by intact membranes. 
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2.3.2 Prevalence 
The reported prevalence of omphalocele varies markedly in literature. Live birth 
prevalence rates ranging from 0.32 to 5.13 in 10,000 have been reported with no 
significant long-term trends in general (Gong et al. 2016, ICBDSR Office 2011, Li 
et al. 2015). A summary of the reported prevalence rates in our literature review can 
be found in Table 4. A recent US study (Mai et al. 2019) and another from Singapore 
(Tan et al. 2008) reported increasing prevalence in their studies differing from other 
findings. The incidence of omphalocele seen on ultrasonography at 14–18 weeks of 
pregnancy is as high as 1 in 1100 (Christison-Lagay et al. 2011). This discrepancy 
between numbers detected in antenatal screening and reported birth prevalence stems 
from high rates of foetal demise and terminations of pregnancy (Forrester & Merz 
1999). Hence, the significant variations in the prevalence of omphalocele can be 
explained by differing cultures and practices regarding planned termination of 
pregnancy due to anomalies. 
2.3.3 Risk Factors 
Several risk factors for omphalocele have been identified in the literature (Table 3). 
Both very young and advanced maternal age are known to be associated with an 
increased risk of omphalocele (Salihu et al. 2003, Frolov et al. 2010, Marshall et al. 
2015). Similarly, maternal obesity and disorders of glycaemic control are well-
recognized risk factors (Waller, D. K. et al. 2001, Waller, D. Kim et al. 2007). Also, 
history of miscarriages, as well as nulliparity, have been reported to be significant 
risk factors (Agopian et al. 2009, Duong et al. 2012, Campaña et al. 2017). Exposure 
to alcohol and smoking in early pregnancy have also been found to be associated 
with an increased risk of omphalocele (Bird et al. 2009, Feldkamp et al. 2014). 
Contrary to gastroschisis, exomphalos does not seem to be associated with low 
socioeconomic status (Kapapa et al. 2019). There are also some reports on maternal 
use of prescription drugs in the first trimester of pregnancy, and an increased risk 
has been associated with exposure to selective serotonin reuptake inhibitors (SSRI) 
(Alwan et al. 2007, Louik et al. 2007), asthma medication (Lin et al. 2012), and 
unspecified antibiotics (Kapapa et al. 2019). Occupational exposure to ionizing 
radiation increases the risk of omphalocele among other major structural birth 
defects (Lim et al. 2015). Additionally, male sex of the foetus/infant significantly 
increases the risk (Goldkrand et al. 2004, Bahado-Singh et al. 2011, Marshall et al. 
2015). Folate and vitamin B12 are important in DNA methylation process, and 
variations in genes associated with them are associated with an elevated risk of 
omphalocele (Mills et al. 2012). As folic acid deficiency is a risk factor for several 
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birth defects, a US study found that grain fortification with folic acid decreased the 
risk for omphalocele along with several other anomalies (Canfield et al. 2005). 
Table 3.  Influence of different exposures and factors on the risk of omphalocele. 
Increased Risk Reduced Risk Controversial 
Young and advanced maternal age 
Maternal obesity  
Alcohol 
Nulliparity  
History of miscarriages 
SSRI 
Male sex 
Folic acid Smoking 
2.3.4 Treatment 
The optimal treatment of exomphalos depends on the size of the defect and on the 
presence of associated malformations. Large defects, i.e. giant omphaloceles 
(Figure 4), pose a great challenge and make up to 50–70% of the cases (Bauman et 
al. 2016). No consensus on the definition of a giant omphalocele has been reached. 
However, most surgeons define them as a defect larger than 5 cm in diameter 
(Whitehouse et al. 2010, Bauman et al. 2016). The size of the defect matters, because 
increased defect size is an independent predictor of mortality (Raymond et al. 2019). 
Ex Utero Intrapartum Treatment (EXIT) has also been proposed as an alternative 
treatment option for giant omphalocele and it appears to be effective and safe, 
yielding results that are comparable with the traditional approach. However, more 
experience is needed before it can be recommended more widely (Chen, X. et al. 
2018). 
The goal of the treatment is reduction of the herniated abdominal contents and 
closure of the defect. Visceroabdominal disproportion is the primary determinant 
when choosing the method of closure (Bauman et al. 2016). Primary closure 
generally consists of resection of the omphalocele sac, approximation of umbilical 
fascial tissue, and closure of the defect. In case of small defects (Figure 3), amenable 
to primary closure, this can often be done easily. However, primary closure should 
not even be attempted in cases with large tissue defects and massive 
visceroabdominal disproportion. Complications, such as abdominal compartment 
syndrome with respiratory compromise, bowel obstruction or ischaemia, or inferior 
vena cava obstruction, are common if primary repair is attempted with giant 
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omphalocele (Hatch & Baxter 1987, Lee et al. 2006, Eijck et al. 2008, Ein & Langer 
2012). Furthermore, the risk of subsequent herniation is over 50% (Eijck et al. 2011). 
Three distinct strategies for managing these cases are nonoperative, delayed 
closure; staged surgical closure; and serial taping followed by surgical closure. 
Reported methods of nonoperative closure include topical silver, iodine, manuka 
honey or aqueous eosin, and negative pressure wound therapy, while staged surgical 
closure has been performed with Proline silo, Silastic silo, and interposition mesh 
(Bauman et al. 2016). Complete epithelialization of the sac often takes months, but 
the resulting hernia can often be closed in a single operation, while staged surgical 
closure obviously requires several operations (Eijck et al. 2008). Serial taping can 
be performed bedside at NICU without anaesthesia, and the defect is later closed 
surgically after the viscera is completely reduced (Kogut & Fiore 2018). Currently 
it seems that nonoperative management with topical silver and delayed closure of 
the fascial defect is associated with lower mortality and shorter time to full feeds 
compared to staged surgical closure (Bauman et al. 2016). Serial taping appears to 
be a promising treatment modality for giant omphalocele (Kogut & Fiore 2018). 
However, no large series comparing these treatment methods exist. 
After surgery, most patients will require mechanical ventilation postoperatively. 
Intra-abdominal pressure will decrease gradually when abdominal wall and bowel 
wall oedema resolves. Enteral feeds can begin when NG aspirates are no longer 
bilious (Christison-Lagay et al. 2011). 
2.3.5 Associated Anomalies 
Other organ anomalies and chromosomal abnormalities are often seen with 
omphalocele; according to previous studies in 27–88% of cases (Stoll et al. 2008, 
Ionescu et al. 2014, Marshall et al. 2015, Fleurke-Rozema et al. 2017). The most 
common association is with cardiac anomalies, which are seen in 7–50% 
(Greenwood et al. 1974, Bianchi 2010, Klein, Michael D. 2012, Marshall et al. 
2015). Reported cardiac anomalies include VSD, ASD, ectopia cordis, tricuspid 
atresia, and coarctation of the aorta (Klein, Michael D. 2012). Association with 
Down syndrome has been reported, and chromosomal abnormalities can be found in 
up to 20% (Reddy et al. 1994, Klein, Michael D. 2012, Stoll et al. 2008). Also, 
musculoskeletal (4–25%, limb reduction deficiencies and club foot most common) 
and neural tube (4–30%, anencephaly and spina bifida most common) defects are 
more common (Ardinger et al. 1987, Loder & Guiboux 1993). Other organ systems 
involved are respiratory (1–4%, hypoplastic lungs), gastrointestinal (3–20%, atresia 
and duplication most common), genitourinary (6–20%, obstructive genitourinary 
defects, cloacal and bladder exstrophy most common), and facial (1–14%, clef lip ± 
palate) (Klein, Michael D. 2012). Pulmonary hypoplasia and/or hypertension is 
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associated with 9.8% of omphalocele cases according to a literature review, and its 
co-occurrence is associated with increased mortality (Saxena & Raicevic 2018). 
Omphalocele can also be associated with syndromes like Beckwith-Wiedemann 
Syndrome (BWS) and OEIS (Omphalocele, bladder Exstrophy, Imperforate anus, 
and Spinal defects) complex (Klein, MD 2012). BWS is an overgrowth syndrome 
with a predisposition for tumour development. Pentalogy of Cantrell is an extremely 
rare congenital anomaly where omphalocele is accompanied by ectopia cordis, lower 
sternal defect and heart malformations and diaphragmatic defect (Jnah et al. 2015). 
2.3.6 Outcome 
It has been estimated, that due to the high rates of planned terminations of pregnancy, 
an elevated risk of intrauterine foetal demise and high perinatal mortality, less than 
10% of the antenatally detected omphaloceles reach the stage of operative repair 
(Lakasing et al. 2006, Marshall et al. 2015, Fleurke-Rozema et al. 2017). Co-
occurring chromosomal abnormalities and organ anomalies are the best predictors of 
survival (Springett et al. 2014, Marshall et al. 2015). In isolated cases, one-year 
survival rates exceeding 90% have been reported (Springett et al. 2014, Marshall et 
al. 2015). Infant mortality (died before age of one year) ranges from 20 to 30% in 
those born with multiple anomalies, while 27–38% of the cases with chromosomal 
defects survive the first year (Salihu et al. 2003, Springett et al. 2014, Marshall et al. 
2015). As omphalocele is seldom an isolated anomaly, the reported overall survival 
rates in literature range from 15 to 54% (Yazbeck et al. 1986, Byron-Scott et al. 
1998, Stoll et al. 2001, Deng et al. 2014, Marshall et al. 2015). Most children with a 
small omphalocele recover well and do not have any long-term complaints 
(Christison-Lagay et al. 2011). However, up to 60% of patients with giant 
omphalocele suffer from persisting medical problems, including gastroesophageal 
reflux, feeding difficulties with failure to thrive, and recurrent chest infections 
(Koivusalo et al. 1999, Biard et al. 2004). We postulate that this may reflect the 
associated anomalies rather than omphalocele itself. 
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Table 4.  Summary of the reviewed articles on omphalocele. Prevalence rates are given per 
10,000 live births if not otherwise mentioned. 
Author  
(data collection years) 
Country 
Type of study 
(n=number of 
cases) 
Prevalence  
(per 10,000) 
Main findings 
Stallings et al. 2019 
(2012 – 2016) 
USA 
Retrospective 
study (n=2,601) 
2.1 Older (>40) and obese (BMI 
>30) mothers have higher risk 
Mai et al. 2019 
(2010 – 2014) 
USA 
Retrospective 
study (n=1,270) 
1.27 Increasing prevalence 
compared to previous periods 
Kapapa et al 2019 
(2000 – 2011) 
Germany 
Retrospective 
case-control study 
(n=18) 
6.6 (in hospital 
prevalence) 
Hormonal treatment increased 
the risk  
Wittekindt et al. 2019 
(2010 – 2015) 
Germany 
Retrospective 
study (n=47) 
1.60 Trisomy 13 and 18, heart 
defects and prematurity 
increased early mortality 
Saxena & Raicevic 2018 
 
UK 
Review of 
literature (n=396) 
- Pulmonary hypertension, 
respiratory failure and ruptured 
sac increased mortality 
Singh & Kumar 2017 
(1992 – 2012) 
Barbados 
Retrospective 
study (n=16) 
2.53 Low mortality (12.5%) 
Bugge et al. 2017 
(1989 – 2015) 
Greenland 
Retrospective 
study (n=4) 
1.5 No trend 
Campaña et al. 2017 
(1967 – 2013) 
Argentina 
Retrospective 
case-control study 
(n=438) 
- Previous repeated miscarriages 
increased the risk 
Kong et al. 2016 
(1992 – 2009) 
Australia 
Retrospective 
study (n=166) 
1.7 No change in prevalence 
Marshall et al. 2015 
(1995 – 2005) 
USA 
Retrospective 
study (n=2,308) 
1.92 Young (<20) and advanced 
(>35) maternal age, multiple 
gestation and male sex 
increased the risk 
Reefhuis et al. 2015 
(1997 – 2009) 
USA 
Retrospective 
case-control study 
- SSRI increased the risk 
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Li et al. 2015 
(1996 – 2010) 
China 
Retrospective 
study (n=1,322) 
1.50 No long-term trends, 
seasonality in rural areas 
Lim et al. 2015 
(1997 – 2009) 
USA 
Retrospective 
case-control study 
(n=264) 
- Ionizing radiation increased risk 
Springett et al. 2014 
(2005 – 2011) 
UK 
Retrospective 
study (n=671) 
3.8 (per 10,000 
births) 
High prevalence 
Benjamin & Wilson 2014 
(1999 – 2008) 
USA 
Retrospective 
study (814) 
2.1 Large proportion had associated 
anomalies (80%) 
Feldkamp et al. 2014 
(1997 – 2007) 
USA 
Retrospective 
case-control study 
(n=301) 
- Active smoking was not 
associated with increased risk, 
but second-hand smoke 
exposure increased the risk 
Lin et al. 2012 
(1997 – 2005) 
USA 
Retrospective 
case-control study 
(n=154) 
- Asthma medication increased 
the risk 
Mills et al. 2012 
(1998 – 2005) 
USA 
Retrospective 
case-control study 
(n=169) 
 Variations in folate and vitamin 
B12-related genes increased 
the risk 
Agopian et al. 2009 
(1999 – 2004) 
USA 
Retrospective 
study (n=325) 
2.16 Advanced maternal age and 
nulliparity as risk factors 
Blomberg et al. 2009 
(1995 – 2007) 
Sweden 
Retrospective 
study (n=103) 
- Obesity (BMI >30) increased 
the risk 
Mac Bird et al. 2009 
(1997 – 2003) 
USA 
Retrospective 
case-control study 
(168) 
 Modestly elevated risk among 
women who used alcohol and 
among women who were heavy 
smokers 
Stoll et al. 2008 
(1979 – 2003) 
 
 
France 
Retrospective 
study (86) 
2.57 Often associated with other 
malformations 
Tan et al. 2008 
(1993 – 2002) 
Singapore 
Retrospective 
study (n=100) 
2.17 Increasing trend 
Arimatias Raitio 
 30
Waller et al. 2007 
(1997 – 2002) 
USA 
Retrospective 
study (n=177) 
- Obesity (BMI>30) increased risk 
Alwan et al. 2007 
(1997 – 2002) 
Canada 
Retrospective 
case-control study 
(n=181) 
- SSRI increased risk 
Louik et al. 2007 
(1993 – 2004) 
USA 
Retrospective 
case-control study 
(n=127) 
- SSRI increased risk 
Canfield et al. 2005 
(1995 – 2000) 
USA 
Retrospective 
study (n=455) 
- Grain fortification with folic acid 
has reduced birth prevalence 
Salihu et al. 2003 
(1992 – 1999) 
USA 
Retrospective 
study (287) 
1.33 Decreasing trend 
Watkins et al. 2003 
(1993 – 1997) 
USA 
Retrospective 
study (n=18) 
- Obesity (BMI>30) increased risk 
Botto et al. 2002 
(1968 – 1980) 
USA 
Retrospective 
case-control study 
(n=41) 
- Maternal febrile illness in early 
pregnancy increased risk 
Bugge et al. 2002 
(1970 – 1989) 
Denmark 
Retrospective 
study (258) 
2.07 (per 10,000 
births) 
No trend 
Stoll et al. 2001 
(1979 – 1998) 
France 
Retrospective 
case-control study 
(58) 
2.18 Medication use more common 
among omphalocele mothers 
Suita et al. 2000 
(1975 – 1997) 
Japan 
Retrospective 
study (970) 
0.32 – 0.74 High number of associated 
anomalies (56%) 
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3 Aims 
The aim of this thesis was to investigate epidemiology and risk factors of abdominal 
wall defects in Finland.  
 
The thesis consisted of four separate studies, and their specific aims were: 
I To assess the prevalence, mortality, associated anomalies, rates of planned 
termination of pregnancy, and to identify possible long-term trends of 
gastroschisis in Finland from 1993 to 2014. 
II To assess the prevalence, mortality, associated anomalies, rates of planned 
termination of pregnancy, and to identify possible long-term trends of 
omphalocele in Finland from 1993 to 2014. 
III To assess and identify potential maternal risk factors of gastroschisis, and 
especially to assess the safety and effects of the medications used during the 
first trimester of pregnancy in Finnish population. 
IV To assess and identify potential maternal risk factors of omphalocele, and 
especially to assess the safety and effects of the medications used during the 
first trimester of pregnancy in Finnish population.
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4 Materials and Methods 
4.1 Methods 
This thesis is a register study based on several national registers upheld by the 
Finnish Institute of Health and Welfare: the Finnish Register of Congenital 
Malformations, the Medical Birth Register, the Register of Induced Abortions, the 
Care Register for Health Care, and the Register of Visual Impairment and National 
Hospital Discharge Register complemented by the Cause of Death statistics collected 
by Statistics Finland. The data on maternal prescription medicine use was obtained 
from the Register on Reimbursed Drug Purchases upheld by the Finnish Social 
Insurance Institution (Kela). These registers receive information based on a legally 
compulsory announcement request on all health personnel in our country. These 
registers contain information on all terminated and born cases with congenital 
anomalies in Finland. Regarding stillbirths and other mortalities, the diagnoses are 
entered in the register according to the autopsy report if a postmortem examination 
has been performed; in other instances, a death certificate is utilized. As antenatally 
detected cases are not reported, we were not able to assess the detection rate of 
antenatal screening for abdominal wall defects. 
After the concept of the thesis was agreed on with all members of the study 
group, we applied for study permits with the Finnish Institute for Health and Welfare 
and locally at Turku University Hospital. The data collection was done by the 
Finnish Institute for Health and Welfare, as only employees are allowed access to 
the register data. After the anonymised data was acquired, it was analysed with the 
help of two statisticians (Löyttyniemi and Kemppainen) under supervision of 
principal investigators (Raitio and Helenius). The first author (Raitio) drafted all the 
manuscripts included in this thesis and handled the submission processes and 
revisions as requested by the journals. Before being submitted to journals, the 
manuscripts were critically revised and accepted by all authors. 
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4.1.1 Antenatal Screening and Legislation 
Every pregnant woman in Finland is entitled to two ultrasound scans during 
pregnancy. The first of these scans is done 10 to 14 weeks after conception. The 
second scan to screen for foetal anomalies takes place at 18 to 21 weeks (Klemetti 
& Hakulinen-Viitanen 2013). According to Finnish legislation, termination of 
pregnancy due to social circumstances can only be done before the 12th week of 
pregnancy. However, termination of pregnancy due to significant foetal anomaly(s) 
is permitted until the end of 24th week of gestation (Suomen laki). This procedure 
always requires authorization by the National Supervisory Authority for Welfare and 
Health (Valvira). 
4.1.2 Epidemiology 
The first two studies are mostly based on the Finnish Register of Congenital 
Malformations data. This registry has been maintained by the National Institute for 
Health and Welfare since 1963. As the “Declaration of Malformation” forms are 
received from the maternity and paediatric hospitals, the list of diagnosis is obtained 
and confirmed with the previously mentioned registries, and additional information 
(patient records, radiographs, photographs, specialist consultation, etc.) is requested 
if deemed necessary before entering the data to the register. All recorded diagnoses 
are evaluated, classified, coded, and double-checked by a medical geneticist, and the 
coverage and data quality of the register have been considered good in several studies 
(Greenlees et al. 2011, Artama et al. 2011, Syvänen et al. 2014). 
The diagnoses in the register are coded according to the International 
Classification of Diseases and Health Related Problems (ICD) by the World Health 
Organization – both ninth and tenth revisions (ICD-9 and ICD-10) were used during 
our study period from January 1, 1993 to December 31, 2014. For our analysis, we 
searched the register for all the cases with codes 756.73 and 756.72 (ICD-9), or 
Q79.3 and Q79.2 (ICD-10) for gastroschisis and omphalocele, respectively, and 
included them in the study. The acquired data contained all live births, stillbirths, 
and planned terminations of pregnancy. However, the first three years of our study 
period contained information only on the live births, as the data on stillbirths and 
terminations of pregnancy only became available in 1997. The data on the Finnish 
Register of Congenital Malformations was then complemented with the data on the 
above-mentioned registers. Birth prevalence and total prevalence are given per 
10,000 births, and live birth prevalence is given per 10,000 live births as defined by 
EUROCAT (EUROCAT Working Group 2019). 
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4.1.3 Case-control Studies 
For our case-control studies, we included cases from January 1, 2004 to December 
31, 2014, as the data on maternal Body Mass Index (BMI) only became available in 
the beginning of 2004. As maternal BMI is significantly associated with the risk of 
gastroschisis (Stothard et al. 2009, Khodr et al. 2013, Jenkins et al. 2014, Baer et al. 
2015) and omphalocele (Waller, D. K. et al. 2001, Waller, D. Kim et al. 2007), it 
was important to include that data on our multivariable analysis on the risk factors 
of abdominal wall defects. 
We selected all previously identified gastroschisis and omphalocele cases born 
between January 1, 2004 and December 31, 2014 for our case-control cohort. Five 
healthy controls matched for maternal age (±1 year), residency, and time of 
conception (±1 month) were randomly selected for each case from the Medical Birth 
Register. For the aborted foetuses, live-born, healthy controls were selected. All 
maternal risk factors in the register were analysed, including BMI, parity, smoking, 
illnesses and history of miscarriages. 
The data on maternal prescription medicine use was obtained from the Register 
on Reimbursed Drug Purchases upheld by the Finnish Social Insurance Institution 
(Kela). The data on maternal drug purchases was limited to a time window of one 
month before conception and the first trimester of pregnancy. The initial analysis on 
maternal medication was done at the 4th level of the Anatomical Therapeutic 
Chemical (ATC) Classification System by WHO. Subsequently, we identified and 
selected those ATC groups with higher frequency of events among cases for further 
analysis. 
4.2 Statistical Analysis 
All risk factors were evaluated with chi-square test or Fisher’s exact test. The 
average age of mothers who had a child with an abdominal wall defect was compared 
with the average age of all mothers who have given birth in Finland with one sample 
t-test. The change in live birth prevalence during our study period was evaluated with 
linear regression. Continuous variables were summarised with mean and standard 
deviation (SD). Categorical variables were summarised with counts (n) and 
percentages (%). For mortality, odds ratios (with 95% confidence interval) were 
calculated where possible.  
For the case-control study, conditional logistic regression was used to evaluate 
different risk factors based on literature and data availability. First, univariate models 
were programmed, and finally multivariable models were created. All significant 
risk factors in univariate models along with risk factors reported in previous studies 
were included in multivariable models. Odds ratios (OR) along with adjusted odds 
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ratios (aOR) with 95% confidence intervals (CI) were calculated. Also, Fisher’s 
exact test was executed to search potential risk factors. All statistical tests were 
performed as two-sided, with a significance level set at p<0.05. The analyses were 
performed using the SAS System, version 9.4 for Windows (SAS Institute Inc., Cary, 
NC, USA).  
4.3 Ethical Aspects 
As required by the Finnish national legislation, the use of the data was authorised by 
the National Institute of Health and Welfare after consulting the data protection 
authority. The approval of the Institutional Review board at Turku University 
Hospital, Turku, Finland, was also obtained before conducting this study. As no 
patients were contacted during these studies, no informed consent was required. All 
data was obtained and stored anonymously. 
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5 Results 
5.1 Epidemiology 
5.1.1 Gastroschisis 
In our review, we identified 320 gastroschisis cases from 1993 to 2014 in Finland, 
including 235 (73.4%) live births, 16 (6.4%) stillbirths, and 69 (21.6%) planned 
terminations of pregnancy. Total prevalence of gastroschisis was 2.57 per 10,000 
births. Birth prevalence (live births and stillbirths) was 1.85/10,000 and live birth 
prevalence was 1.73 per 10,000 live births. During our study period, the live birth 
prevalence of gastroschisis increased significantly, even though the number of 
stillbirths and abortions remained constant. (p=0.0018) – Figure 5. Gastroschisis 
was rarely associated with other birth defects, and almost 95% of cases were 
classified as ‘simple gastroschisis’. 
The majority of infants with gastroschisis were born slightly preterm, on 36th 
week on average. Caesarean section (N=146, 58%) was more common than vaginal 
delivery (N=105, 42%). Gastroschisis was significantly associated with lower than 
average maternal age (mean 24.3 [SD 4.6] years vs 30.0 years, p<0.001). 
Infant mortality of gastroschisis was low, 7.7% (18/235). Simple gastroschisis 
had slightly lower mortality, 7.2% (16/222), while complex cases with bowel 
compromise and/or atresia had higher mortality (15%, 2/13). The mode of delivery, 
maternal obesity, diabetes and smoking had no impact on mortality. Interestingly, 
mothers who opted for termination of pregnancy were significantly older than those 
who decided to continue their pregnancy (mean age 28.8 [SD 6.4] years vs 24.3 [SD 
4.6] years, p<0.001). 
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Figure 5.  Increasing trend in live birth prevalence of gastroschisis in Finland. 
5.1.2 Omphalocele 
Our register search identified 600 cases with omphalocele: 332 (55%) abortions and 
268 (45%) births, of which 229 (38%) were live births and 39 (6.5%) stillbirths. 
Total prevalence of omphalocele in Finland was 4.71 per 10,000 births with no 
consistent trend over time. Birth prevalence and live birth prevalence were much 
lower; 1.96 and 1.69 in 10,000 respectively (Figure 6). No changes in abortion rates 
were observed during our study period. However, termination of pregnancy was 
significantly more common in the southern parts of Finland, as presented in Table 
5. Also, the maternal age was significantly higher in those who opted for termination 
than in those who continued with pregnancy (mean age 32.0 [SD 6.4] years vs 30.0 
[SD 6.0] years, p<0.001). 
On average, infants with omphalocele tend to be born prematurely (average 36.4 
weeks of gestation), and in total, there were 135 (50%) premature babies in our 
cohort (<38 gestational weeks). Vaginal delivery was favoured in most cases (152 
vaginal births vs 116 caesarean sections).  Omphalocele is often associated with 
other major anomalies, as summarised in Table 6. Most common co-occurring 
anomalies were chromosomal abnormalities (trisomy 18, trisomy 13, and trisomy 21 
being the most common), heart defects (VSD and ASD being the most common) and 
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central nervous system (hydrocephaly, anencephaly, and spina bifida being the most 
common) and gastrointestinal anomalies (intestinal atresia and cloacal anomalies 
being the most common). Interestingly, only 8 infants (3.0%) had Beckwith-
Wiedemann syndrome. Congenital diaphragmatic hernia was found in total of 6 
infants/foetuses (1.0%). 
 
Figure 6.  Live birth prevalence of omphalocele in Finland. 
At the age of one year, 179 (78%) patients were alive. Hence, the overall infant 
mortality of omphalocele was 22%. Mortality was highest among those with 
chromosomal abnormalities. No differences between tertiary centres were detected 
(Table 5). However, there was a significant decline in the mortality rate during our 
study period after the first five years (p=0.03), as demonstrated in Table 7. Maternal 
diabetes (p=0.45), obesity (OR: 0.93, 95% CI 0.28 to 3.12), smoking (OR: 0.78, 95% 
CI 0.38 to 1.68), hypertension (p=0.59), and mode of delivery (OR for caesarean: 
0.65, 95% CI 0.34 to 1.22) had no impact on the infant mortality. 
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Table 5.  Case distribution of omphalocele cases in Finland from 1993 to 2014. No differences 
were found in survival. However, termination of pregnancy was significantly more 
common in the south coast of Finland (Helsinki and Turku) compared with the rest of 
the country (p=0.03). 
Tertiary Centre Number of live births Infant mortality (%) Abortion rate (%) 
Helsinki 72 26.4 68.9 
Turku 21 19.1 66.7 
Tampere 21 25.5 48.5 
Kuopio 40 17.5 51.1 
Oulu 33 21.2 53.0 
 
Table 6.  The most common anomalies associated with omphalocele. 
 Chromosomal Heart CNS* Gastrointestinal Urogenital Skeletal 
Born (n=268 12 (4.5%) 17 (6.3%) 4 (1.5%) 8 (3.0%) 8 (3.0%) 8 (3.0%) 
Aborted (n=332 44 (13%) 4 (1.2%) 14 (4.2%) 4 (1.2%) 4 (1.2%) 4 (1.2%) 
All (n=600) 56 (9.3%) 21 (6.3%) 18 (3.0%) 12 (2.0%) 12 (2.0%) 12 (2.0%) 
* CNS: Central nervous system 
 
Table 7.  Survival and infant mortality of omphalocele in Finland 1993 – 2014. 
 Number of cases Infant mortality (%) 
Isolated omphalocele 176 19.9 
Multiple anomalies 41 12.2 
Chromosomal abnormalities 12 83.3 
Total 229 21.8 
1995 – 1999 43 34.9 
2000 – 2004 54 11.1 
2005 – 2009 48 18.8 
2010 – 2014 45 17.8 
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5.2 Risk factors 
5.2.1 Gastroschisis 
For the case-control study, we identified 188 cases of gastroschisis and compared 
them with 910 matched controls (see paragraph 4.1.2). In univariate analysis, 
nulliparity was a significant risk factor for gastroschisis, OR 1.65 (95% CI 1.14 – 
2.39). Similarly, smoking appeared to increase the risk for gastroschisis, however 
not significantly: OR 1.35 (95% CI 0.92 – 1.99). Also, the use of oral 
pseudoephedrine (World Health Organization’s ATC code R01BA) during the first 
trimester of pregnancy suggested an elevated risk of gastroschisis, OR 10.0 (95% CI 
0.91 – 110). In Finland, pseudoephedrine is only available with a prescription and as 
a combination drug with different antihistamines (desloratadine, acrivastine or 
cetirizine) (Pharmaca Fennica 2019).  
 
 
 
Figure 7.  Adjusted odds ratios for maternal risk factors of gastroschisis. Significant association 
was observed with nulliparity and maternal obesity.  
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Maternal obesity was associated with a significantly lower risk of gastroschisis, OR 
0.39 (95% CI 0.16 – 0.91) and maternal age for gastroschisis cases was significantly 
lower than mean maternal age in the Finnish population (mean 24.3 [SD 4.6] years 
vs 30.0 years, p<0.001). Also, gestational diabetes moderately decreased the risk of 
gastroschisis, OR 0.49 (95% CI 0.22– 1.09). As a strong interaction was observed 
between maternal BMI and gestational diabetes (p<0.001), we created new 
combination variables for multivariable models. 
The associations were similar in our multivariable analysis: nulliparity, aOR 2.00 
(95% CI 1.29 – 3.11), smoking, aOR: 1.32 (95% CI 0.88 – 1.97), and 
pseudoephedrine, aOR 5.45 (95% CI 0.49 – 60.8) increasing the risk, while obesity 
was protective, aOR 0.35 (95% CI 0.15, 0.83) – (Figure 7). Analysing obesity and 
gestational diabetes separately revealed the risk to be associated with obesity rather 
than hyperglycaemia. All analysed maternal risk factors are summarised in Table 8 
and prescription drugs in Table 9. The number of previous miscarriages, maternal 
diabetes, the sex of the newborn/foetus, and other maternal medications in early 
pregnancy did not affect the risk of gastroschisis. 
Table 8.  Univariate analysis of the maternal risk factors for gastroschisis in Finland 1993 –2014. 
 Number of Events Odds ratio 
(95% CI) 
Cases 
(n=147–188) 
Controls 
(n=880–910) 
Maternal Obesity (BMI >30) 7147 (4.8%) 93/880 (10.6%) 0.39 (0.16 – 0.91) 
Maternal low body weight  
(BMI <18.5) 
10/147 (6.8%) 59/880 (6.7%) 0.89 (0.43 – 1.85) 
Nulliparity 129/188 (68.6%) 536/910 (58.9%) 1.65 (1.14 – 2.39) 
Smoking 52/150 (34.7%) 248/891 (27.8%) 1.35 (0.92 – 1.99) 
Previous miscarriage(s) 35/187 (18.7%) 137/910 (15.1%) 1.22 (0.79 – 1.89) 
Pregestational diabetes 3 /154 (2.0%) 17/910 (1.9%) 1.09 (0.22 – 3.98) 
Gestational diabetes 7/154 (4.6%) 86/910 (9.5%) 0.49 (0.22 – 1.09) 
Male sex 86/153 (56.2%) 454/910 (49.9%) 1.39 (0.94 – 1.92) 
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Table 9.  Univariate analysis of all analysed prescription drugs used in early pregnancy and their 
association with the risk of gastroschisis in Finland 1993 – 2014. 
 Number of Events Odds ratio 
(95% CI) 
Cases  
(n=172) 
Controls  
(n=838) 
Penicillin 20 (11.6%) 104 (12.4%) 0.97 (0.58 – 1.62) 
Non-steroidal anti-
inflammatory drugs 
12 (7.0%) 75 (9.0%) 0.72 (0.38 – 1.39) 
Inhaled steroids 10 (5.8%) 36 (4.3%) 1.44 (0.70 – 2.95) 
Hormonal drugs for 
infertility 
2 (1.2%) 15 (1.8%) 0.70 (0.16 – 3.19) 
Antihistamines 8 (4.7%) 24 (2.9%) 1.65 (0.70 – 3.89) 
Pseudoephedrine  2 (1.2%) 1 (0.1%) 10.0 (0.91 – 110) 
5.2.2 Omphalocele 
Between January 1, 2004 and December 31, 2014, we found 359 cases of 
omphalocele and compared them with 1738 matched controls (see paragraph 4.1.2). 
In univariate analysis, nulliparity was a significant risk factor for omphalocele, OR: 
1.46 (95% CI 1.15 – 1.86). There were 226 obese mothers (BMI ≥30) in our cohort 
(12.7%) and obesity was associated with a higher risk of omphalocele, OR 2.03 (95% 
CI 1.21 – 3.42). Similarly, maternal low body weight (BMI <18.5) was associated 
with the risk for omphalocele, OR 1.63 (95% CI 0.66 – 4.04). In addition, 
newborns/foetuses with omphalocele were more likely to be male, although it did 
not reach statistical significance, OR 1.27 (95% CI 0.87 – 1.87).  
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Table 10.  Univariate analysis of all analysed maternal risk factors for omphalocele in Finland 1993 
– 2014.  
Note: Missing values due to fewer data stored in the Register of Induced Abortions. 
 
Oral use of extended spectrum penicillins (WHO’s ATC Code J01CA: amoxicillin 
or pivmecillinam) during the first trimester of pregnancy had a protective influence 
on the risk of omphalocele, OR 0.44 (95% CI 0.25 – 0.77). The number of previous 
miscarriages, maternal diabetes, and smoking had no influence on the risk. 
Furthermore, no significant changes in risk were observed with the use of non-
steroidal anti-inflammatory drugs (M01AB, M01AE), antihistamines (R06AE, 
R06AX), inhaled steroids (R01AD, R03BA), or the hormonal drugs used to treat 
infertility (G03DA, G03GA, H01CA, H01CC, L02AE). A summary of the analysed 
maternal risk factors can be found in Table 10 and analysed prescription drugs in 
Table 11. 
 Number of Events Odds ratio 
(95% CI) 
Cases 
(n=122–359) 
Controls 
(n=1662–1738) 
Maternal BMI ≥30 26/122 (21.3%) 200/1662 (12.0%) 2.03 (1.21 – 3.42) 
Maternal BMI <18.5 8/122 (6.6%) 58/1662 (3.5%) 1.63 (0.66 – 4.04) 
Nulliparity 167/359 (46.5%) 638/1738 (36.7%) 1.46 (1.15 – 1.86) 
Smoking 17/128 (13.6%) 243/1703 (14.3%) 0.92 (0.50 – 1.70) 
Previous miscarriage (1) 65/344 (18.9%) 304/1738 (17.5%) 1.14 (0.83 – 1.57) 
Previous miscarriages 
(≥2) 
35/344 (10.2%) 129/1738 (7.4%) 1.52 (1.00 – 2.31) 
Pregestational diabetes 6/130 (4.6%) 39/1738 (2.2%) 1.35 (0.67 – 2.74) 
Gestational diabetes 22/130 (16.9%) 200/1738 (11.5%) 1.35 (0.67 – 2.74) 
Male sex 76/129 (58.9%) 866/1738 (49.8%) 1.27 (0.87 – 1.87) 
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Table 11.  Univariate analysis of all analysed prescription drug exposures in early pregnancy. 
 Number of Events Odds ratio  
(95% CI) 
Cases  
(n=328) 
Controls  
(n=1656) 
Extended spectrum 
Penicillins 
15 (4.6%) 151 (9.1%) 0.44 (0.25 – 0.77) 
Non-steroidal anti-
inflammatory drugs 
23 (7.0%) 134 (8.1%) 0.87 (0.54 – 1.41) 
Inhaled steroids 17 (5.2%) 95 (5.7%) 0.87 (0.50 – 1.52) 
Hormonal drugs for 
infertility 
14 (4.3%) 66 (4.0%) 1.10 (0.60 – 2.01) 
Antihistamines 14 (4.3%) 77 (4.7%) 0.94 (0.52 – 1.70) 
 
The protective effects of extended spectrum penicillins were confirmed in our 
multivariable analysis, aOR 0.15, (0.04 – 0.64), whereas nulliparity was not 
significantly associated with an increased risk (aOR 1.25, 0.80 – 1.95). Even though 
previous miscarriages were not associated with an increased risk in univariate 
analysis, history of two or more miscarriages was a statistically significant risk factor 
in the multivariable model (2.39, 1.10 – 5.18). Due to strong interaction (p<0.0001), 
a combination variable was created to analyse maternal obesity and both 
pregestational and gestational diabetes. An elevated risk was observed with both 
types of diabetes and maternal obesity and the risk accumulated further with co-
occurrence of these two risk factors. (Figure 8) 
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Figure 8.  Adjusted odds ratios for maternal risk factors of omphalocele. Significant associations 
were observed with extended spectrum penicillins, multiple miscarriages, maternal 
obesity, and gestational diabetes. 
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6 Discussion 
6.1 Gastroschisis 
Our main findings on gastroschisis cohort were increasing prevalence, high rate of 
abortions, and low rates of associated anomalies and mortality. A higher risk of 
gastroschisis was associated with young maternal age, nulliparity, maternal smoking 
and pseudoephedrine use in early pregnancy. Maternal obesity significantly 
mitigated the risk of gastroschisis. 
Increasing prevalence of gastroschisis is a well-recognised and worldwide 
phenomenon (Castilla et al. 2008, Jones et al. 2016, Brebner et al. 2018, Bhatt et al. 
2018). Our study confirms these observations, as we also found a significantly 
increasing trend in live birth prevalence of gastroschisis in Finland from 1993 to 
2014, while no significant trend was observed in the number of induced abortions. 
In addition, the prevalence has increased significantly from the reported numbers 
from the 1970s by Hemminki et al. (Hemminki et al. 1982). Even though all reports 
have been consistent on the increasing prevalence worldwide, no clear explanation 
has been found. However, the use of recreational drugs, a known risk factor for 
gastroschisis (Draper et al. 2008), has increased in Finland since 1992 (Alcohol and 
Drug Statistics 2018). Additionally, there has been a marked increase in the number 
of blended families in Finland since the 1990s (Väisänen & Helamaa 2014), and 
short length of sexual cohabitation appears to be associated with an elevated risk 
(Rittler et al. 2007). Furthermore, there has been a marked increase in genital herpes 
infections since the 1970s (Vuorenmaa et al. 2012), and the infection itself and/or 
the antiherpetic drugs have been found to be associated with a higher risk of 
gastroschisis (Ahrens et al. 2013). Similarly, chlamydia infections predispose to an 
increased risk of gastroschisis (Dewberry et al. 2020) and chlamydia infections have 
also become more common from 1995 to 2010 (Vuorenmaa et al. 2012). We 
speculate that altered exposure to certain risk factors could be associated with the 
increasing prevalence in Finland. 
Infant mortality for gastroschisis in Finland was in keeping with previous 
reports, 7.7% (Lao et al. 2010, Owen et al. 2010, Cowan et al. 2012, Brindle et al. 
2012, Overcash et al. 2014, Brebner et al. 2018). For obvious reasons, those with 
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complex gastroschisis had higher mortality, but due to a rather small number of 
patients, it did not reach statistical significance (p=0.26). Even though maternal 
obesity, smoking and diabetes have been identified risk factors for infant mortality 
in gastroschisis, their impact on mortality was no significant in our series. The 
proportion of stillbirths was in range with other studies, 6% (Brantberg et al. 2004, 
Nicholas et al. 2009, South et al. 2013). 
Gastroschisis was an isolated anomaly in most cases and our data were 
concordant with previous studies (Nicholas et al. 2009, Bhatt et al. 2018, Brebner et 
al. 2018). However, we only had 5% of complex cases with bowel necrosis, atresia, 
or volvulus, while it is usually seen in 13 – 20% of cases according to literature 
(Bergholz et al. 2014, Bhatt et al. 2018, Mutanen et al. 2018). We believe it is 
possible, that co-occurring conditions and associated anomalies may not be reported 
as accurately as the main diagnosis in the registers. 
There is a clear trend towards Caesarean delivery with pregnancies affected by 
gastroschisis, also in our series (Brebner et al. 2018, Lopez et al. 2019). As most 
cases are detected antenatally, this allows planning and selecting optimal mode and 
time of delivery. However, there is no evidence of the benefits of Caesarean section 
on clinical outcomes including mortality, sepsis, primary repair, duration of 
parenteral nutrition, and hospital stay (Nicholas et al. 2009, Kirollos & Abdel-Latif 
2018, Lopez et al. 2019). We would encourage a practise where neonatal and surgical 
teams could take part in planning the optimal time and mode of delivery, as 
obstetricians may not have sufficient knowledge of the condition of the 
foetus/neonate and the treatment required after birth. Personal communication with 
colleagues verifies that this type of practise is currently provided in many of the 
university hospitals in our country. 
Rates of abortion for any reason vary markedly due to regional practises related 
to culture, religion, and legislation. Generally, termination rates for gastroschisis 
vary from 5 to 14% (Nicholas et al. 2009, Ekin et al. 2015, Fleurke-Rozema et al. 
2017). Our study revealed that Finland has, to the best of our knowledge, the highest 
rate of planned termination of pregnancy due to gastroschisis. In our series, 22% of 
cases were terminated. If those not detected in prenatal screening had been excluded, 
the proportion of families opting for abortion would have been even higher. We 
found this high abortion rate controversial, as gastroschisis was often an isolated 
anomaly in our series, and mortality rates were also low. We hypothesise that this 
might be due to insufficient antenatal counselling provided for the families when 
they how pregnancy is complicated by gastroschisis. We believe that it would be 
beneficial for all the families with a pregnancy affected by gastroschisis to meet both 
neonatal and paediatric surgical teams to discuss the risks and required treatment 
associated with this condition. 
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Young maternal age was a significant risk factor for gastroschisis, and several 
previous reports support this finding (Loane et al. 2007, Vu et al. 2008, Chabra et al. 
2011, Robledo-Aceves et al. 2015). Consistent with previous reports, we also found 
nulliparity to be a significant risk factor (Rittler et al. 2007, Duong et al. 2012). 
However, as Rittler et al. compared epidemiologic variables between primiparae and 
multiparae, and between those who had and had not changed partners, only length 
of cohabitation showed significant risk (Rittler et al. 2007). They found no 
significant risk associated with nulliparity or change of paternity alone, and 
speculated that some antigenic or immunologic factors could be involved in the 
origin of gastroschisis. 
Smoking is one of the most commonly agreed upon risk factors of gastroschisis 
(Draper et al. 2008, Hackshaw et al. 2011, Perry et al. 2019, Hawkins & Baum 2019) 
known to alter the mechanical and functional properties of placental arteries, which 
may compromise the foetal placental blood flow (Clausen et al. 1999). In our series, 
the risk associated with smoking did not reach statistical significance, possibly due 
to limited number of exposures. It seems evident, however, that smoking is 
associated with an increased risk of gastroschisis. A recent US study also found that 
tobacco tax increases reduced the prevalence of gastroschisis among other birth 
defects (Hawkins & Baum 2019). 
Even though we had a small number of exposures in the pseudoephedrine group, 
our results support earlier findings regarding the association between an elevated 
risk of gastroschisis and pseudoephedrine (Werler et al. 1992, Torfs et al. 1996, 
Werler et al. 2002). Pseudoephedrine is a vasoconstrictive decongestant (Brunton et 
al. 2017), available in Finland only with a prescription and combined with 
antihistamines (Pharmaca Fennica 2020). As the risk did not increase with exposure 
to antihistamines alone, we believe that the influence is associated with the 
vasoconstrictive characteristics of pseudoephedrine. Both smoking and 
pseudoephedrine have vasoactive influence. Having both as risk factors supports the 
theory of disruption of umbilical vasculature in early pregnancy being the origin of 
gastroschisis. 
Protective influence of maternal obesity on the risk of gastroschisis has been 
established in several studies (Stothard et al. 2009, Khodr et al. 2013, Jenkins et al. 
2014, Baer et al. 2015). Due to direct correlation between maternal age and weight, 
a systematic review published in JAMA speculated that the decreased risk of 
gastroschisis in obese mother would be caused by the inverse correlation of risk of 
gastroschisis and maternal age. However, we also found maternal obesity to be 
protective despite having age-matched controls. Hence, maternal obesity appears to 
be an independent protective factor for gastroschisis regardless of maternal age as 
reported by Baer et al. (Baer et al. 2015) Previous studies have associated maternal 
diabetes with both an increased (Skarsgard et al. 2015) and a decreased (Baer et al. 
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2015, Given et al. 2017) risk of gastroschisis. According to our results, it appears 
that protective influence could be associated with obesity rather than diabetes. 
Regardless, hyperglycaemia does not seem to be associated with an increased risk. 
6.2 Omphalocele 
The main findings on our omphalocele cohort were high mortality among those with 
chromosomal defects, but relatively good outcome without. We also found that 
isolated cases were more common in Finland than previously reported. Regardless, 
omphalocele is often associated with other anomalies, and therefore abortion is often 
chosen. Maternal obesity and history of previous miscarriages increase the risk for 
omphalocele. We found the use of extended spectrum penicillins during the first 
trimester of pregnancy to be associated with a significantly lower risk of 
omphalocele. 
Live birth prevalence of omphalocele is strongly dependant on the abortion rates. 
However, the prevalence in Finland remained constant during our study period, and 
similar static trends have been also reported earlier (ICBDSR Office 2011, Li et al. 
2015, Marshall et al. 2015, Gong et al. 2016). Our prevalence trend in Finland was 
decreasing, but not statistically significantly. A similar observation was also made 
in two US studies previously (Salihu et al. 2003, Marshall et al. 2015). This might 
be at least partially explained by improved antenatal detection rates, as abortion rates 
nearly doubled in the Netherlands after their prenatal screening program was 
introduced (Fleurke-Rozema et al. 2017). Another possible explanation could be that 
in western countries the influences of folic acid and/or vitamin B12 deficiencies are 
currently only seen among those with variances in genes related to them (Canfield 
et al. 2005, Mills et al. 2012). The proportion of planned terminations was also high 
in our cohort, 55%. However, this is keeping with other reports in western countries 
(Brantberg et al. 2005, Nicholas et al. 2009, Fleurke-Rozema et al. 2017). 
Interestingly, maternal age for those who opted for termination of pregnancy was 
significantly higher than the maternal age of those who decided to continue with the 
pregnancy. In our series, this trend was seen in pregnancies with both gastroschisis 
and omphalocele. It has been speculated that older women may have greater 
concerns with potential offspring health (Virgo & Sear 1997). They may also feel 
more pressured to undergo the antenatal examination and act according to the 
findings (Kelhä 2009). 
To our surprise, only 23% of our omphalocele cases had associated anomalies, 
while previous studies have reported other anomalies among 27–88% of the cases 
(Stoll et al. 2008, Ionescu et al. 2014, Marshall et al. 2015, Fleurke-Rozema et al. 
2017). Similarly, we also had a lower number of abnormal karyotypes in both 
aborted foetuses (13%) and born infants (5%) comparing with 17–49% aneuploidy 
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rates in other reports (Brantberg et al. 2005, Marshall et al. 2015, Fleurke-Rozema 
et al. 2017). Even though our register data quality has been validated to be accurate 
and to have high coverage, we speculate that there might be some reporting bias 
especially among stillbirths, as those were all classified as isolated cases of 
exomphalos. Alternatively, it is possible that death certificates have been created in 
these instances according to the apparent diagnoses without requesting a postmortem 
examination. 
The mortality related to omphalocele is best predicted by the presence of co-
occurring chromosomal abnormalities and organ anomalies (Springett et al. 2014, 
Marshall et al. 2015). Our overall mortality of 22% is at the lower range of mortality 
rates reported in previous studies (15–54%) (Yazbeck et al. 1986, Byron-Scott et al. 
1998, Stoll et al. 2001, Deng et al. 2014, Marshall et al. 2015). Infant mortality 
among cases with chromosomal abnormalities ranges from 27 to 38%, while in our 
cohort only 17% survived the first year. On the other hand, cases with multiple 
anomalies in our cohort had infant mortality of only 12%. Both may be affected by 
a reasonably low number of cases in these two groups. Isolated cases in our cohort 
had a 20% infant mortality. However, as previously mentioned, there may be some 
degree of reporting bias involved. 
The reports on the association between maternal medication and omphalocele 
have been contradictory (Alwan et al. 2007, Källén & Olausson 2007). There is 
limited evidence on the elevated risk associated with maternal asthma medication 
(Lin et al. 2012) and unspecified antibiotics (Kapapa et al. 2019). In our series, 
maternal use of inhaled steroids was not associated with an elevated risk of 
omphalocele, and the use of oral extended spectrum penicillins significantly 
mitigated the risk both in univariate and multivariable analysis. Previously, maternal 
febrile illness has been found to be a risk factor for omphalocele (Botto et al. 2002). 
As half of omphalocele cases are born prematurely (Raitio et al. 2020) and 
chorioamniotic microorganisms are also more likely to be found from women with 
preterm labour (Hillier et al. 1988), it is possible that chorioamnionitis could be 
associated with both prematurity and omphalocele. Additionally, one dose of 
amoxicillin given at birth has been found to significantly reduce the prevalence of 
umbilical hernias in a case-control study on newborn piglets (Yun et al. 2017). We 
speculate that microbiological factors may play a role in the pathogenesis explaining 
the protective role of penicillins. 
Maternal obesity is a well-established risk factor for omphalocele and several 
other birth defects, including spina bifida, hypospadias, heart defects, anorectal 
malformations, limb reductions, and congenital diaphragmatic hernia (Watkins et al. 
2003, Waller, D. Kim et al. 2007, Blomberg & Källén 2010, Auger et al. 2020). The 
mechanism remains unclear. However, there is substantial evidence provided by 
both human and animal studies that disorders of glycaemic control are responsible 
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for an increased risk of structural birth defects (Becerra et al. 1990, Eriksson et al. 
2003). Therefore, it has been speculated that similar mechanisms may be responsible 
for the elevated risk of birth defects in obese mothers (Waller, D. Kim et al. 2007). 
According to our results, both obesity and diabetes are associated with an increased 
risk, and co-occurrence of these risk factors accumulates the risk. 
There is also limited evidence that maternal smoking is a risk factor for 
omphalocele. According to previous reports, an elevated risk has been associated 
with heavy smoking (Bird et al. 2009) and second-hand smoke exposure (Feldkamp 
et al. 2014). Paradoxically, Feldkamp et al. (2014) found no risk to be associated 
with active smoking, and no dose-response relationship was observed. In keeping 
with this and the results of a German group (Kapapa et al. 2019), maternal smoking 
was not significantly associated with an increased risk of omphalocele in our study. 
Even though male sex is a known risk factor for omphalocele (Goldkrand et al. 2004, 
Bahado-Singh et al. 2011, Marshall et al. 2015), the association was not significant 
in our series. 
6.3 Limitations 
The main limitation in all the studies in this thesis is their retrospective design. 
Furthermore, they all rely on the accuracy of the national registers. On the other 
hand, as already mentioned earlier, the data quality and coverage of these registers 
have been considered good in several national and international studies (Gissler et 
al. 1995, Pakkasjärvi et al. 2006, Leoncini et al. 2010, Greenlees et al. 2011, Artama 
et al. 2011, Syvänen et al. 2014, Kela 2019). As gastroschisis and omphalocele are 
both apparent congenital anomalies with little risk of misdiagnosis, we believe that 
the cases are recorded in an accurate manner. However, there may be some bias 
regarding the co-occurring anomalies, especially among stillbirths and those who 
died in early days of life. We speculated on this possibility after noticing that all 
stillbirths with omphalocele were reported as “isolated omphalocele”, which is 
unlikely to be the case. This could be explained by doctors creating death certificates 
without requesting a postmortem examination. Similarly, there was a 
disproportionate amount of mortalities among cases reported as isolated 
omphaloceles, while cases with reported multiple anomalies had higher infant 
mortality. These factors were the main limitations and the source of possible bias in 
the first two studies (I & II) of this thesis.  
Studies III and IV aimed to assess and identify risk factors for abdominal wall 
defects. Hence, the possible underreporting of associated anomalies did not influence 
these results. However, we had to limit these studies to cover years 2004 – 2014, 
even though the data on maternal medication was available for the whole study 
period from January 1993. Maternal BMI is significantly associated with the risk of 
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both gastroschisis and omphalocele, and became available in the register only in 
January 2004. Hence, to be able to create reliable multivariable models, we had to, 
unfortunately, limit the data on risk factors for the last ten years of our study period. 
An additional limitation regarding our data on maternal prescription drugs is that 
even though the data itself is accurate and limited to the critical time window of one 
month before conception and the first trimester of pregnancy, we had no means of 
confirming if the mothers actually used the drugs they purchased. The other 
limitation of our risk factor analysis was the lacking data on socioeconomic status 
and alcohol consumption, both of which are recognized as risk factors for abdominal 
wall defects (Bird et al. 2009, Richardson et al. 2011, Bronberg et al. 2020, Freitas 
et al. 2020, Baldacci et al. 2020). 
Regarding statistical analysis, we believe that the biggest risk of bias comes from 
analysing several different potential risk factors, which unavoidably increases the 
risk of coincidence, rather than true association, explaining the statistically 
significant findings. However, our results were in keeping with previous reports for 
the most part regarding the risk factors for both gastroschisis and omphalocele. 
6.4 Future considerations 
Several studies have aimed to explain the worldwide increasing trend in prevalence 
of gastroschisis. Our findings did confirm the increasing prevalence but failed, 
however, to provide an explanation. According to our findings, maternal use of 
prescription drugs does not appear to significantly increase the risk of gastroschisis. 
Hence, we feel that an explanation for this trend should be sought elsewhere.  
Further studies are warranted to confirm our novel findings regarding the 
association of extended spectrum penicillins and the risk of omphalocele. If our 
results are confirmed, microbiological factors should be considered as a potential 
etiological explanation behind the failure of closure of the umbilical ring and 
development of omphalocele. 
6.5 Prevention strategies 
To minimize the risk of abdominal wall defects, the prevention strategies should be 
aimed at those risk factors that can be influenced. Smoking increases the risk for 
gastroschisis, and a US study has already shown that cigarette tax increases 
effectively reduced the number of birth defects (Hawkins & Baum 2019). Folic acid 
deficiency, a risk factor for several birth defects (Canfield et al. 2005), is already 
taken into account in our prenatal clinics. Maternal obesity is a significant risk factor 
for several birth defects with gastroschisis as an exception. Gestational diabetes also 
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increases the risk of birth defects, and these two risk factors have a strong interaction, 
as our results have shown. Similarly, alcohol consumption is a known risk factor for 
both gastroschisis and omphalocele. According to our results and previous studies, 
the majority of prescription drugs are safe regarding the risk of abdominal wall 
defects. However, certain drugs should be used cautiously, if at all, by women trying 
to conceive. Special consideration should be given to the use and necessity of SSRI 
drugs and pseudoephedrine during early pregnancy. Also, attention should be paid 
to sexual health and sexually transmitted diseases, as both chlamydia and herpes 
infections increase the risk of gastroschisis, and their rates are rising in Finland. 
In conclusion, several risk factors for abdominal wall defects have been 
identified, but the majority of them are challenging to influence, as they are related 
to a western lifestyle and diet. However, cigarette tax increases could provide a 
method to reduce the risk of several birth defects. The potential role of extended 
spectrum penicillins in the pathogenesis of omphalocele suggests an interesting topic 
for future research. Similarly, the mechanism behind the association of maternal 
obesity and reduced risk of gastroschisis needs to be further explored.
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7 Summary/Conclusions 
The prevalence and mortality rates of both gastroschisis and omphalocele in Finland 
are comparable with those reported in other high-income countries. Hence, we 
conclude that the quality of care in Finland for these anomalies is good. 
 
The following conclusions have been drawn based on the results of our studies: 
1. The prevalence of gastroschisis is increasing in Finland, and despite low 
mortality rate, a high number of pregnancies are terminated. 
2. Survival rates of omphalocele in Finland are high, and isolated cases are 
more common than previously reported. Termination of pregnancy is 
more commonly chosen in Southern Finland compared with the rest of the 
country. 
3. Young maternal age and nulliparity are significant risk factors for 
gastroschisis, while maternal obesity mitigates the risk. No significant risk 
was observed with any maternal prescription drug exposures. 
4. Maternal obesity and history of repeated miscarriages increase the risk of 
omphalocele. Extended spectrum penicillins significantly reduced the risk 
of omphalocele, and this novel association warrants further studies. 
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